Not provided
Not provided
Not provided
Not provided
Funding issues
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Colorado, Denver | OTHER |
| QED Clinical, Inc | UNKNOWN |
| Children's Hospital of Philadelphia | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The specific aim of this cluster-randomized (site) comparative effectiveness research study is to determine whether children who are (1) 5-12 years of age, (2) cared for in ePROS practices or clinics using an electronic health record (EHR), (3) have attention-deficit hyperactivity disorder (ADHD), and (4) are to receive treatment with stimulant medication for the first time in these practices, have superior clinical outcomes if their clinicians have access to an EHR-guided clinical decision support system (intervention group) than if their clinicians have no such access (control group).
In this cluster (site)-randomized trial of clinical decision support for ADHD medication titration, clinicians caring for children with ADHD whose families are initiating stimulant medication at that practice will be followed.
Two groups will be compared; an intervention group, which will receive the intervention-the clinical decision support (CDS)--, and a control group, who will not receive CDS. Over a 6-month period, the CDS will support guideline-based medication titration to achieve optimal symptom control with minimal side effects. The study will track the care delivered to affected children by the practitioners and will assess the endpoints of symptom reduction and side effects. There will also be a sub-study within the larger study which will give the team a better understanding about the pros and cons of consenting parents over the phone.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control practices | No Intervention | Practices that do not use the ADHD clinical decision support | |
| Clinical decision support | Experimental | Electronic health record-based clinical decision support for ADHD medication titration. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Clinical decision support for medication titration | Behavioral | Electronic health record-based clinical decision support for ADHD medication titration. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Improvement in symptoms, as measured by the parent-reported Vanderbilt Assessment Scale. | This intervention study tests a clinical decision support system for ADHD treatment. | 4 & 6 months after enrollment |
| Measure | Description | Time Frame |
|---|---|---|
| Side effects as reported on the ADHD Vanderbilt Scale. | We will compare side effects between the intervention and control groups. | 4 & 6 months after enrollment |
Not provided
Practice Eligibility Criteria
Patient Eligibility Criteria
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Richard C Wasserman, MD, MPH | University of Vermont | Principal Investigator |
| Alexander G Fiks, MD, MSCE | Children's Hospital of Philadelphia | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| American Academy of Pediatrics | Elk Grove Village | Illinois | 60007 | United States |
Not provided
| Label | URL |
|---|---|
| ePROS website | View source |
Not provided
Not provided
| ID | Term |
|---|---|
| D001289 | Attention Deficit Disorder with Hyperactivity |
| ID | Term |
|---|---|
| D019958 | Attention Deficit and Disruptive Behavior Disorders |
| D065886 | Neurodevelopmental Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided